<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="GBP" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-GOV-13-FUND--GCRF-BB_N007492_1</iati-identifier>
  <reporting-org ref="GB-GOV-13" type="10">
   <narrative xml:lang="EN">Department of Business, Energy and Industrial Strategy</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">A new drug discovery pipeline for animal African trypanosomiasis</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">A new drug discovery pipeline for animal African trypanosomiasis</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">It is estimated that some 45-50 million cattle, in addition to millions of goats, pigs and sheep, are at risk of African animal
trypanosomiasis (AAT) in tsetse-infected areas of up to 10 million km2. Impacts include milk &amp; beef production, calving
rates and mortality, with an estimated annual cost to the region of $4.5 billion; a further key parameter is the impact upon
draught animals such as equines and oxen, and their ability to work - clearly affecting agricultural production in many ways.
The disease impact is particularly severe in endemic sub-Saharan regions, where the rearing of livestock is the main
livelihood of small communities, and agriculture is the main driver of the developing economies. Currently, only two options
exist for treatment of AAT: diminazene aceturate and isometamidium chloride. Both treatments are &gt;50 years old and suffer
from widespread resistance, but the resistance mechanisms are poorly understood, preventing effective surveys of
resistance incidence. Both the identification of resistance markers and the development of new drugs are among the
highest priorities for agricultural development in Africa.
Our systems pharmacology platform will address both issues and is part of the BBSRC strategic priority of Animal Health,
which is &apos;to support fundamental and strategic research leading to the development of intervention strategies for combating
endemic and exotic infectious diseases (including vector borne and zoonotic disease)&apos;. The identification of resistance
mechanisms and markers will allow a far more accurate assessment of the AAT situation and inform intervention
strategies. The introduction of new drugs will enable sustainable increases of agricultural production and food security - key
BBSRC objectives.
Furthermore, the proposed research addresses the causes of Antimicrobial Resistance (AMR), another major BBSRC
priority area. Specifically, the work will contribute to &apos;the fundamental microbiology of organisms with known resistance
prevalence in order to understand how resistance develops and is maintained, and develop mitigation strategies&apos;.
Importantly, the BBSRC strategy calls for &apos;Research that will inform strategies for combatting the development of AMR in
managed animals&apos;, tying it into the food safety/agricultural themes. The direct impact of any improvement in AAT control on
African food production would be very substantial at both local and regional levels.
Importantly, we propose, in partnership with the major stakeholder GALVMed, a new and much-improved paradigm for
addressing AMR and drug development, constituting a major new application of systems biology and conforming to the
BBSRC call of &apos;Exploiting New Ways of Working&apos;. Systems approaches to the Biosciences are in themselves a BBSRC
priority and applications for the &apos;better countering of diseases or pests (including parasites) of crops or farmed animals&apos; are
especially encouraged. The generic platform of using metabolomics and transcriptomics in an integrated approach together
with traditional biochemical and pharmacological techniques that we propose to create and validate here provides valuable
training in key priority areas and as such impacts on the future UK skills base, with posts created for a senior postdoc in
systems biology/pharmacology and a position in the bioinformatics analysis of the multi-disciplinary datasets, which will
optimise structure-activity relationships within test series as well as create many novel insights in parasite metabolism. The
skills, and indeed the entire systems-pharmacology approach, can be applied to many similar problems of AMR and lead
optimisation in a drug development context.
While the proposal is innovative the applicants have the combined track record and expertise to ensure genuine impact as
here outlined, bringing together experts with major track records in polyomics, trypanosome genetics, drug resistance
mechanisms and drug development for neglected parasitic diseases.</narrative>
  </description>
  <participating-org ref="GB-GOV-13" role="1" type="10">
   <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
  </participating-org>
  <participating-org role="3" type="90">
   <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2016-01-01" type="1"></activity-date>
  <activity-date iso-date="2016-07-01" type="2"></activity-date>
  <activity-date iso-date="2018-12-31" type="3"></activity-date>
  <activity-date iso-date="2019-12-31" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">International Development</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">GCRF</narrative>
   </person-name>
   <email>gcrf@ukri.org</email>
   <website>https://www.ukri.org/</website>
   <mailing-address>
    <narrative xml:lang="EN">Polaris House, Swindon, SN2 1LF</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="UG" percentage="100">
   <narrative xml:lang="EN">Uganda</narrative>
  </recipient-country>
  <recipient-region code="1027" percentage="100" vocabulary="1"></recipient-region>
  <sector code="43082" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Research/scientific institutions</narrative>
  </sector>
  <tag code="RI" vocabulary="99" vocabulary-uri="https://devtracker.fcdo.gov.uk/custom-codes">
   <narrative xml:lang="EN">Research and Innovation</narrative>
  </tag>
  <collaboration-type code="4"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-01-25"></transaction-date>
   <value currency="GBP" value-date="2016-01-25">299815.67</value>
   <description>
    <narrative xml:lang="EN">BBSRC GCRF Responsive Mode Award to University of Edinburgh</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB/N007492/1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-01-01"></transaction-date>
   <value currency="GBP" value-date="2017-01-01">24783.36</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-04-01"></transaction-date>
   <value currency="GBP" value-date="2017-04-01">24783.36</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-07-01"></transaction-date>
   <value currency="GBP" value-date="2017-07-01">24984.1</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-10-01"></transaction-date>
   <value currency="GBP" value-date="2017-10-01">24984.1</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-01-01"></transaction-date>
   <value currency="GBP" value-date="2018-01-01">24984.1</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-04-01"></transaction-date>
   <value currency="GBP" value-date="2018-04-01">24984.1</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-07-01"></transaction-date>
   <value currency="GBP" value-date="2018-07-01">25186.47</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-10-01"></transaction-date>
   <value currency="GBP" value-date="2018-10-01">25186.47</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="GBP" value-date="2019-01-01">25186.47</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-04-01"></transaction-date>
   <value currency="GBP" value-date="2019-04-01">8395.47</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-01"></transaction-date>
   <value currency="GBP" value-date="2019-07-01">8395.5</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-01"></transaction-date>
   <value currency="GBP" value-date="2020-04-01">8395.29</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-BB_N007492_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org ref="GB-UKPRN-10007790">
    <narrative xml:lang="EN">University of Edinburgh</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/HTTP" url="http://gtr.rcuk.ac.uk/projects?ref=BB%2FN007492%2F1">
   <title>
    <narrative xml:lang="EN">Abstract/Planned Impact</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
   <document-date iso-date="2016-07-01"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.ukri.org/funding/information-for-award-holders/grant-terms-and-conditions/">
   <title>
    <narrative xml:lang="EN">UK Research &amp; Innovation Grant Terms and Conditions</narrative>
   </title>
   <category code="A04"></category>
  </document-link>
  <conditions attached="1"></conditions>
 </iati-activity>
</iati-activities>
